Hyperandrogenism Induces Histo-Architectural Changes in the Rat Uterus

Reprod Sci. 2019 May;26(5):657-668. doi: 10.1177/1933719118783881. Epub 2018 Jun 21.

Abstract

The effects of androgens on the uterus have been poorly studied and they need to be clarified to understand why androgen excess, such as observed in women with polycystic ovary syndrome (PCOS), is a risk factor for the development of endometrial hyperplasia, cancer, and infertility. Thus, uterine histomorphology in a PCOS experimental model was evaluated. Beginning at weaning, female rats were injected daily with dehydroepiandrosterone (DHEA, 6 mg/100 g body weight) or vehicle (sesame oil) for 20 consecutive days. On postnatal day 41 (PND41), DHEA-treated animals showed high serum testosterone levels. In addition, uterine histological analysis showed a significant increase in luminal epithelial height and glandular density without changes in cell proliferation. The thickness of the subepithelial stroma and myometrium also increased in these animals. The effect of DHEA on uterine thickness was accompanied by a significant reduction in cell density in both tissue compartments (subepithelial stroma and myometrium). Cell proliferation was not altered in the myometrium, whereas a decrease in the proliferative activity was seen at PND41 in the subepithelial stroma of DHEA animals. The analysis of the extracellular space showed that the changes in the thickness of the subepithelial stroma and myometrium were related to an increase in the organization of collagen fibers and water imbibition. The latter was associated with higher aquaporin 3 and 8 expression. This study provides evidence to further the understanding of PCOS-associated hyperandrogenism effects on uterine architecture. This could have implications for the regulation of uterine function and the development of uterine lesions.

Keywords: aquaporin; cell proliferation; collagen; dehydroepiandrosterone; uterus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Dehydroepiandrosterone / administration & dosage
  • Disease Models, Animal
  • Estrogen Receptor alpha / metabolism
  • Female
  • Hyperandrogenism / chemically induced
  • Hyperandrogenism / metabolism
  • Hyperandrogenism / pathology*
  • Polycystic Ovary Syndrome / chemically induced
  • Polycystic Ovary Syndrome / metabolism
  • Polycystic Ovary Syndrome / pathology*
  • Rats, Wistar
  • Receptors, Androgen / metabolism
  • Uterus / metabolism
  • Uterus / pathology*

Substances

  • Estrogen Receptor alpha
  • Receptors, Androgen
  • Dehydroepiandrosterone